Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Maravai Lifesciences Holdings (MRVI) Return on Capital Employed (2021 - 2025)

Maravai Lifesciences Holdings has reported Return on Capital Employed over the past 5 years, most recently at 0.28% for Q4 2025.

  • Quarterly results put Return on Capital Employed at 0.28% for Q4 2025, down 6.0% from a year ago — trailing twelve months through Dec 2025 was 0.28% (down 6.0% YoY), and the annual figure for FY2025 was 0.25%, down 6.0%.
  • Return on Capital Employed for Q4 2025 was 0.28% at Maravai Lifesciences Holdings, down from 0.24% in the prior quarter.
  • Over the last five years, Return on Capital Employed for MRVI hit a ceiling of 0.33% in Q1 2022 and a floor of 0.37% in Q2 2025.
  • Median Return on Capital Employed over the past 5 years was 0.07% (2023), compared with a mean of 0.04%.
  • Biggest five-year swings in Return on Capital Employed: grew 18bps in 2022 and later tumbled -33bps in 2025.
  • Maravai Lifesciences Holdings' Return on Capital Employed stood at 0.31% in 2021, then fell by -13bps to 0.27% in 2022, then plummeted by -107bps to 0.02% in 2023, then tumbled by -1127bps to 0.22% in 2024, then dropped by -30bps to 0.28% in 2025.
  • The last three reported values for Return on Capital Employed were 0.28% (Q4 2025), 0.24% (Q3 2025), and 0.37% (Q2 2025) per Business Quant data.